Can you say, "the sixth sheik's sixth's sheep's sick?" Maybe so, but many of your patients can't when they leave your office. Now you can legally inject them with a drug to make such tongue twisters ...
Novalar Pharmaceuticals used the Chicago Dental Society Midwinter Meeting to officially unveil OraVerse, the first local anesthesia reversal agent that accelerates the return to normal sensation and ...
A new study published in the Feb. 2012 issue of Anesthesiology found that the type of lipid emulsion used to reverse toxicity of local anesthetics may change the effectiveness of the reversal, ...
For some people, it's the whine of the drill, the sound of suction or those intimidating dental tools that make them dread the dentist. For Diane, it's that frozen feeling. "Having to get numbed up ...
Novalar Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and in-licensing novel oral healthcare solutions, announced today that it has closed a $30 million Series D ...
SAN DIEGO, May 12 /PRNewswire/ -- Novalar Pharmaceuticals, Inc., a dental specialty pharmaceutical company, announced today that the United States Food and Drug Administration (FDA) has granted ...
Novalar has received approval to market OraVerse (phentolamine mesylate injection) for the reversal of soft-tissue anesthesia and the associated functional deficits resulting from a local dental ...
SAN DIEGO, Nov. 1 -- Novalar Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and in-licensing novel oral healthcare solutions, announced today that it has closed a $30 ...
Safety in pediatric sedation relies on strict guidelines and monitoring, so let's learn how providers utilize pharmacological ...
Around 10 to 30 percent of people have anxiety and concerns about pain with dental procedures. Anxiety can delay getting treatment and that can make the problem worse. Anesthetics have been around for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results